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Schizophrenia is a debilitating and heritable mental disorder
associated with lower reproductive success. However, the
prevalence of schizophrenia is stable over populations and
time, resulting in an evolutionary puzzle: how is schizophrenia
maintained in the population, given its apparent fitness costs?
One possibility is that increased genetic liability for
schizophrenia, in the absence of the disorder itself, may confer
some reproductive advantage. We assessed the correlation and
causal effect of genetic liability for schizophrenia with number
of children, age at first birth and number of sexual partners
using data from the Psychiatric Genomics Consortium and UK
Biobank. Linkage disequilibrium score regression showed little
evidence of genetic correlation between genetic liability for
schizophrenia and number of children (rg ¼ 0.002, p ¼ 0.84),
age at first birth (rg ¼ 20.007, p ¼ 0.45) or number of sexual
partners (rg ¼ 0.007, p ¼ 0.42). Mendelian randomization
indicated no robust evidence of a causal effect of genetic
liability for schizophrenia on number of children (mean
difference: 0.003 increase in number of children per doubling
in the natural log odds ratio of schizophrenia risk, 95%
confidence interval (CI): 20.003 to 0.009, p ¼ 0.39) or age at
first birth (20.004 years lower age at first birth, 95% CI:
20.043 to 0.034, p ¼ 0.82). We find some evidence of a
positive effect of genetic liability for schizophrenia on
number of sexual partners (0.165 increase in
royalsoc
2the number of sexual partners, 95% CI: 0.117–0.212, p ¼ 5.3010210). These results suggest that
increased genetic liability for schizophrenia does not confer a fitness advantage but does increase
mating success.ietypublishing.org/journal/rsos
R.Soc.open
sci.6:1810491. Introduction
Schizophrenia is a severe, debilitating mental disorder that is substantially heritable [1]. The prevalence of
schizophrenia remains stable over populations and time, and yet is associated with lower reproductive
success for those diagnosed [1–5]. This creates an evolutionary puzzle: how is schizophrenia
maintained in the population despite apparent negative selection? Multiple theories have been proposed
to explain this paradox [3,6,7]. One is mutation–selection balance, which suggests that selection against
detrimental variants is counteracted by the continuous occurrence of new mutations [8,9]. Another is
that effects over many common genetic variants are individually too weak to be under negative
selection [1,8,10].
Another popular theory is that stabilizing selection operates, where the optimum fitness level for a
trait is approximately at the mean of the trait and fitness declines along a normal distribution on
either side of this optimum [3,6,11,12]. A related hypothesis is that schizophrenia-related traits may
demonstrate ‘cliff-edge’ effects on fitness, so that fitness increases with increased expression of the
trait until a threshold, where increased expression then results in a steep decline in fitness for some
individuals [1,12]. Some have suggested that this peak occurs at levels of symptoms that could result
in a diagnosis of schizophrenia, with a reproductive advantage among healthy individuals with an
increased genetic liability for the disorder (in the absence of the disorder itself ) compensating for the
lower reproductive success of those with the disorder itself [1,4,12–14]. Behaviourally, it is possible
that higher genetic liability for schizophrenia may be associated with attractive traits (e.g. creativity)
and therefore also with a greater number of children [4,13]. For example, schizotypy, a personality
measure of schizophrenia-proneness, has been shown to be associated with creativity, short-term
mating interest and mating success [4,13,15], while genetic liability for schizophrenia is associated
with the increased risk of unprotected sex [16].
Relatives of people with schizophrenia are assumed to have an intermediate level of genetic liability
for the highly heritable disorder [17]. Studies into whether cliff-edge fitness maintains the prevalence of
schizophrenia have therefore largely focused on family studies. However, despite extensive research,
there is no clear evidence of increased fecundity in relatives of individuals with schizophrenia [2,7,17].
Del Giudice [17] argued that family studies underestimate the reproductive benefits of schizophrenia-
proneness in the general population. He highlights that relatives share not only genetic liability for
schizophrenia but also their environments, which may hinder fitness and result in apparent negative
selection [17]. It is therefore important to investigate a potential reproductive advantage of
schizophrenia-proneness in the wider population, rather than relying on family studies alone.
Moreover, it is important to investigate causal relationships between schizophrenia risk and
reproductive success, rather than relying on observational methods previously used, which do not
support strong causal inference due to bias from residual confounding and reverse causation [18].
These family studies also suggest that optimum fitness could occur before the appearance of
symptoms that might result in the diagnosis of schizophrenia. The principal measure of fitness is the
number of children, used in the present study; however, both earlier age at first birth and increased
numbers of sexual partners have previously been used as indicators of reproductive success,
particularly in developed populations in which contraception is commonly used to control family size
[4,8,19,20]. Earlier age at first birth probably results in a longer reproductive period, whereas the
number of sexual partners captures mating success and hence potential reproductive success [4].
Recent developments in genetic epidemiology mean that it is now possible to investigate the effects of
genetic liability for schizophrenia in the wider population. A genome-wide association study (GWAS)
identified 128 independent genetic variants from 108 loci associated with schizophrenia that explained
approximately 3.4% of the observed variation in schizophrenia risk [21]. These variants have been
used to show that genetic liability for schizophrenia (using a risk score comprising these individual
variants) is positively associated with creativity [22]. Evidence for associations between genetic
liability for schizophrenia and age at first birth is mixed. Higher genetic liability for schizophrenia
was found for those with a young (e.g. below 20 years) age at first birth compared to those with an
intermediate age at first birth [23,24]. Another study found no clear evidence for linear or quadratic
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also used schizophrenia-associated variants to investigate whether genetic liability for schizophrenia is
associated with number of children, but results were again inconclusive, perhaps due to limited
power [8,25]. The studies showed estimates in the direction of a reproductive advantage, but
confidence intervals are typically wide and consistent with no effect [8,25]. Nevertheless, these studies
demonstrate how genetic liability for schizophrenia can be measured in the wider population.
We applied a range of methods with roots in genetic epidemiology to test part of the cliff-edge
hypothesis. For our main analysis, we examine whether increasing genetic liability for schizophrenia
increases reproductive success in a largely post-reproductive population-based sample which is not
selected on schizophrenia status, and, therefore, includes very few cases. This linear increase is
predicted for part of cliff-edge fitness where a reproductive advantage among healthy individuals
with higher genetic liability for the disorder compensates for lower reproductive success of those with
the disorder itself. Additionally, given suggestions from family studies that there may be a fitness
decline of healthy individuals with high genetic liability for the disorder, we conducted sensitivity
analyses to investigate a possible nonlinear relationship where at very high levels of genetic score
for schizophrenia liability, there is decreased reproductive success in the absence of schizophrenia
itself [2,7,17].
For our main analysis, we calculated genetic correlations using linkage disequilibrium (LD) score
regression between genetic liability for schizophrenia and reproductive success, measured as number
of children, age at first birth and number of sexual partners. Furthermore, we used genetic variants
associated with schizophrenia within a Mendelian randomization (MR) framework to estimate the
causal effect of genetic liability for schizophrenia on these measures of reproductive success. MR uses
single-nucleotide polymorphisms (SNPs), which are assigned at conception and are mostly
independent from other variants or environments. MR therefore overcomes some limitations of
observational studies previously used to investigate this evolutionary paradox, by reducing bias from
confounding and reverse causation [18]. Finally, we estimated the effect of genetically predicted
educational attainment on the number of children and age at first birth. Higher genetically predicted
education is known to be associated with fewer children and delayed age at first birth [25–29]. As the
present study applied MR in a novel context to this evolutionary paradox, we therefore included
educational attainment as an exposure with these two outcomes (using the same outcome datasets
used for our schizophrenia analysis) as a positive control.2. Methods
2.1. Exposure data
We used independent SNPs associated with schizophrenia (p, 5  1028) from the Psychiatric Genomics
Consortium GWAS (N ¼ 35 123 cases and 109 657 controls) [21]. The 128 SNPs identified explained
approximately 3.4% of the observed variance in schizophrenia risk. A total of 101 SNPs remained due
to availability in UK Biobank, availability of proxies and meeting exclusion criteria (see electronic
supplementary material). Odds ratios (ORs) and standard errors (s.e.) for the 101 SNP and
schizophrenia associations were recorded using GWAS data for Europeans only [30]. The final 101
SNPs and effect estimates for schizophrenia genetic variants are listed in electronic supplementary
material, table S1.
For educational attainment, we used SNPs associated with educational attainment ( p, 5  1028)
from a recent GWAS by the Social Science Genetic Association Consortium [31]. As the GWAS
conducted a replication in UK Biobank, effect estimates from the pooled sex analysis of the discovery
sample were used to avoid sample overlap. Sixty-seven SNPs were available in UK Biobank data and
met exclusion criteria. Effect estimates used for educational attainment genetic variants are listed in
electronic supplementary material, table S2.2.2. Outcome data
The exposure-associated SNPs described above were extracted from UK Biobank to derive SNP-outcome
associations for our outcome data. Extraction was done using PLINK (v. 2.00) and best guess algorithms
for determining alleles (full genotyping information below).
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UK Biobank is a population-based health research resource consisting of approximately 500 000 people,
aged between 38 and 73 years, who were recruited between the years 2006 and 2010 from across the UK
[32]. Particularly focused on identifying determinants of human diseases in middle-aged and older
individuals, participants provided a range of information (such as demographics, health status,
lifestyle measures, cognitive testing, personality self-report, and physical and mental health measures)
via questionnaires and interviews; anthropometric measures, blood pressure readings and samples of
blood, urine and saliva were also taken. A full description of the study design, participants and
quality control (QC) methods has been published [33].
2.2.2. Genotyping information in UK Biobank
The full data release contains the cohort of successfully genotyped samples (N ¼ 488 377). A total of
49 979 individuals were genotyped using the UK BiLEVE array and 438 398 using the UK Biobank
axiom array. Pre-imputation QC, phasing and imputation are described elsewhere [34]. In brief,
prior to phasing, multiallelic SNPs or those with minor allele frequency (MAF) less than or equal
to 1% were removed. Phasing of genotype data was performed using a modified version of the
SHAPEIT2 algorithm [35]. Genotype imputation to a reference set combining the UK10 K haplotype
and Haplotype Reference Consortium (HRC) reference panels [36] was performed using IMPUTE2
algorithms [37]. The analyses presented here were restricted to autosomal variants within the HRC
site list using a graded filtering with varying imputation quality for different allele frequency ranges.
Therefore, rarer genetic variants are required to have a higher imputation Info score (Info . 0.3 for
MAF. 3%; Info. 0.6 for MAF 1–3%; Info. 0.8 for MAF 0.5–1%; Info. 0.9 for MAF 0.1–0.5%)
with MAF and Info scores having been recalculated on an in-house-derived ‘European’ subset.
Individuals with sex-mismatch (derived by comparing genetic sex and reported sex) or individuals
with sex-chromosome aneuploidy were excluded from the analysis (N ¼ 814). We restricted the
sample to individuals of white British ancestry who self-report as ‘White British’ and who have very
similar ancestral backgrounds according to the principal component analysis (PCA) (N ¼ 409 703), as
described by Bycroft et al. [34]. Estimated kinship coefficients using the KING toolset [38] identified
107 162 pairs of individuals [34]. An in-house algorithm was then applied to this list and
preferentially removed the individuals related to the greatest number of other individuals until no
related pairs remain. These individuals were excluded (N ¼ 79 448). Additionally, two individuals
were removed due to them relating to a very large number (greater than 200) of individuals. QC
protocol is described elsewhere [39].
2.2.3. Outcome measures
We derived the number of children and age at first birth similarly to previous analyses in UK Biobank
[28]. Participants were either asked how many children they had given birth to or how many children
they had fathered. We further derived a binary variable to indicate if participants were childless or
not (childlessness coded as 1). Age at first birth was only measured in females in UK Biobank, with
participants asked: ‘How old were you when you had your first child?’. If participants indicated that
they had had sexual intercourse, they were asked ‘About how many sexual partners have you had in
your lifetime?’. Participants were given the information that ‘Sexual intercourse includes vaginal, oral
or anal intercourse’ if they activated the help button. We coded responses to missing if above the 99th
percentile. We then derived a binary measure indicating if participants were in approximately the top
10th percentile for the highest number of sexual partners (equal to or above 12 partners coded as 1).
Although no age restrictions were applied in analyses, the nature of UK Biobank data meant that
participants were aged towards the end of their reproductive lives.
2.3. Data analysis
We used LD score regression [40,41] to calculate the genome-wide genetic correlation (rg) between
schizophrenia liability or predicted educational attainment and number of children, age at first birth and
number of sexual partners. Genome-wide associations were conducted for these outcomes using linear
regression, implemented in PLINK v. 2.00 through the Medical Research Council Integrative
Epidemiology Unit GWAS pipeline [42]. In this, we adjusted for the top 10 principal components. For the
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then filtered results on MAF (greater than 0.01) and imputation quality (greater than 0.8) separately.
InMR analyses, datawere harmonized to ensure that the effect of the SNPon the exposure and the SNP
on the outcome corresponded to the same allele. The increasing allele for schizophrenia liability and
educational attainment was used. Associations for exposure SNPs and all outcome measures were then
calculated in R, fitting the same covariates as listed above. Effect sizes for number of children, age at first
birth and number of sexual partners analysis are listed in electronic supplementary material, tables S1
and S2. SNP-exposure and SNP-outcome data were combined using an inverse variance weighted (IVW)
approach which is analogous to a weighted regression of SNP-outcome coefficients on SNP-exposure
coefficients with the intercept constrained to zero [43], and further assumes all variants are valid
instruments or allows pleiotropy to be balanced across instruments when using the random effect [44]
with Cochran’s Q providing a measure of any overdispersion (see electronic supplementary material).
The IVW effect estimate will only be consistent if all genetic variants in the analysis are valid.
Weighted median, mode-based estimator and MR-Egger regression are complementary approaches
that can be used to investigate the impact of invalid instruments on our effect estimates. The weighted
median estimates a consistent effect estimate if at least 50% of the instruments are valid [45]. The
mode-based estimator provides a consistent effect estimate when the largest number of similar
individual-instrument estimates come from valid instruments, even if the majority are invalid [46]. A
tuning parameter of 0.5 was set for mode-based estimator analysis. One of the main assumptions
underpinning MR is that of no horizontal pleiotropy (i.e. no direct effect of the genetic variant on the
outcome that does not act through the exposure) [47]. MR-Egger regression analysis can be used to
further investigate this; MR-Egger does not constrain the intercept to zero and the intercept term
therefore estimates overall directional pleiotropy [48]. We calculated F-statistics (mean of the squared
SNP-exposure association divided by the squared s.e. for SNP-outcome association) to indicate the
strength of instrument, and I2GX statistics to assess the suitability of MR-Egger (above 0.9 is desired)
[47]. Analysis was repeated after removing the few schizophrenia cases in our sample. All analysis
was also conducted with SNP-outcome associations additionally adjusted for genotype array.
MR results were multiplied by 0.693 to represent the causal estimate per doubling in odds of
schizophrenia risk [49]. For childlessness and highest number of sexual partners as outcomes, all MR
results were multiplied by 0.693 on the log-odds scale, and then exponentiated. The reported
estimates therefore indicate the effect of doubling the odds of schizophrenia on the odds of
childlessness or being in the highest number of sexual partners category. The effects of education on
childlessness were converted to ORs by exponentiating log ORs.
As an illustration of shape of the schizophrenia liability–reproductive success relationship, we
created an additive unweighted genetic score for schizophrenia liability in UK Biobank. The score was
created in R (v. 3.2.0), with missing SNP data replaced with the mean value for that SNP across
individuals. We then divided this score into quintiles and deciles and plotted the mean number of
children, age at first birth and number of sexual partners across these categories of the genetic score.
We additionally plotted these relationships with reproductive success on the x-axis. As sensitivity
analysis to assess if there was any decline in reproductive success within our sample at very high
levels of genetic liability, we conducted a series of linear regressions in Stata (v. MP 15.1) between this
genetic score for schizophrenia liability and our outcomes, systematically removing cumulative
centiles from the maximum. This analysis included adjustment for the top 10 principal components
and was repeated after removing the few schizophrenia cases in our sample. Similarly, to further
investigate a possible peak in reproductive success at high genetic liability for schizophrenia, we
conducted quadratic regression analysis of the genetic score for schizophrenia liability and our
outcomes (adjusted for the top 10 principal components and additionally adjusted for sex and age at
assessment where appropriate). Lastly, we repeated quadratic analysis separately for each sex.
Analysis scripts are available on GitHub [50].3. Results
In our sample, from UK Biobank, there were more females than males, a majority had children and a
minority had college or university degree qualifications (electronic supplementary material, table S3).
The mean age was 56.9 years (s.d.: 8.0) and the mean years of education was 13.3 (s.d.: 4.4). For our
outcomes, the mean number of children was 1.8 (s.d.: 1.2), mean number of sexual partners was 5.8
(s.d.: 8.6) and the mean age at first birth was 25.4 years (s.d.: 4.5).
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We found a modest negative genetic correlation between educational attainment-associated variants
and number of children (rg ¼ 20.35, p ¼ 8.57  10241) and a strong positive genetic correlation
between educational attainment-associated variants and age at first birth (rg ¼ 0.81, p , 5  10241)
(table 1). The number of individuals in this analysis was 283 723 for educational attainment, 333 628
for number of children and 123 310 for age at first birth data. There was a total of 1 117 154 SNPs
included in analysis.
Educational attainment variants showed a mean F-statistic (strength of instrument) of 33.23, with
above 10 indicating acceptable levels of relative bias (less than 10%) [44,51]. We applied multiple MR
methods with IVW results reported throughout the text, and other methods only when not consistent.
We found that educational attainment had a negative effect on number of children (mean difference:
20.16, 95% confidence interval (CI): 20.21 to 20.12, p ¼ 3.63  10210 per year increase in educational
attainment) and a positive effect on age at first birth (mean difference: 2.68, 95% CI: 2.40–2.95, p,
5  10214) per year increase in educational attainment (table 2). We also found an effect of increased
education on increased likelihood of being childless (OR: 1.60, 95% CI: 1.47–1.75, p ¼ 1.60  10214 per
year increase in educational attainment). Results for all educational attainment analysis with genotype
array included as a covariate in our outcome summary statistics are presented in electronic
supplementary material, tables S4 and S5.
3.2. Genetic liability for schizophrenia
Using LD score regression, we found little evidence of genetic correlations (rg) between schizophrenia
liability and number of children (rg ¼ 0.002, p ¼ 0.84), age at first birth (rg ¼ 20.007, p ¼ 0.45) and
number of sexual partners (rg ¼ 0.007, p ¼ 0.42) (table 1). The number of individuals included was
35 123 cases and 109 657 controls for schizophrenia liability, 333 628 for number of children, 123 310
for age at first birth and 273 970 for number of sexual partners data. The analysis included 1 114 456 SNPs.
The mean F-statistic for schizophrenia genetic liability was 35.15. There was little evidence that higher
genetic liability for schizophrenia increased number of children (mean difference: 0.003 increase in the
number of children per doubling in the natural log OR of schizophrenia liability, 95% CI: 20.003 to
0.009, p ¼ 0.39) or decreased age at first birth (20.004 years lower age at first birth, 95% CI: 20.043 to
0.034, p ¼ 0.82) (table 2). We further tested childlessness as an outcome and found no strong evidence
of an effect of genetic liability for schizophrenia on childlessness (table 2). We found that higher
genetic liability for schizophrenia had a positive effect on number of sexual partners (0.165 increase in
number of sexual partners, 95% CI: 0.117–0.212, p ¼ 5.30  10210) (table 2). A positive effect was
also seen in the analysis of our binary measure for the highest number of sexual partners (table 2).
We repeated the MR analysis after removing the few schizophrenia cases in our sample (maximum
N ¼ 207) with no clear change in results. Results for these analyses with genotype array included as a
covariate in our outcome summary statistics are presented in electronic supplementary material,
tables S4 and S5.
Our sensitivity analysis investigating a possible nonlinear relationship is presented in
figures 1–3, showing the mean number of children, sexual partners and age at first birth for
quintiles of an unweighted additive genetic score for schizophrenia liability. Although these figures
are somewhat suggestive of a nonlinear relationship between the genetic score for schizophrenia
liability and mean age at first birth, there is little evidence of heterogeneity across values of the
schizophrenia score. The relationship between the genetic score for schizophrenia liability and number
of sexual partners appears more linear. Similar patterns are seen across deciles of the genetic score for
schizophrenia liability and when plotting these measures of reproductive success on the x-axis
(electronic supplementary material, figures S1–S6). A series of regressions between the genetic score
and age at first birth, systematically removing cumulative centiles from the maximum, suggests that
the relationship is strongest at intermediate levels. It appeared that estimates became slightly stronger
in the analysis with number of children, although there was little statistical support (table 3).
This analysis was repeated after removing the few schizophrenia cases in UK Biobank (maximum N ¼
207), which did not alter these results (electronic supplementary material, table S6). Regression of the
genetic score for schizophrenia liability and number of children showed no clear evidence, also when
including a quadratic term for genetic liability for schizophrenia and when stratified by sex (table 4).
This quadratic relationship suggested a slight peak in fitness at intermediate levels of the genetic
liability, particularly for females, but again with little statistical support (electronic supplementary
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Figure 1. Genetic score for schizophrenia liability (in quintiles) and mean number of children in UK Biobank data showing little
evidence of heterogeneity across values of the score.
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showing little evidence of heterogeneity across values of the score.
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10material, figures S7–S9). Regression of the genetic score for schizophrenia liability on age at first birth
showed no clear evidence; however, there was a weak association when including a quadratic term
for the genetic score, suggesting lowest age at first birth was seen at intermediate levels of genetic
liability (table 4; electronic supplementary material, figure S10). For the number of sexual partners, the
relationship appeared to be linear, with no clear evidence when including a quadratic term (table 4;
electronic supplementary material, figures S11–S13)4. Discussion
Our results do not indicate a genetic correlation between genetic liability for schizophrenia and
reproductive success using LD score regression, or a linear causal effect on number of children and
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Figure 3. Genetic score for schizophrenia liability (in quintiles) and mean number of sexual partners in UK Biobank data suggesting
a linear relationship.
royalsocietypublishing.org/journal/rsos
R.Soc.open
sci.6:181049
11age at first birth using MR techniques. This is inconsistent with cliff-edge fitness maintaining
schizophrenia in the population, which would predict an increase in fitness with increased genetic
liability in the general population. These results support previous research suggesting no strong
evidence of a relationship between genetic liability for schizophrenia and number of offspring [8,25].
We find an effect of increasing genetic liability for schizophrenia on increasing number of sexual
partners, suggesting liability for the disorder increases mating success in the wider population and
could reflect potential reproductive success [4]. Results of our positive control analyses were as
expected and in line with previous genetic research, suggesting that educational attainment is under
negative selection [25–29], which suggests that the overall approach we adopted here is valid.
Also consistent with previous research, we found no clear evidence for a linear association between
genetic liability of schizophrenia and age at first birth [8] and weak evidence of a nonlinear association
[24]. In these sensitivity analyses, we found some suggestion of a possible peak in fitness at intermediate
to high levels of genetic liability, but there was no statistical evidence for this, suggesting that if this
nonlinear association exists, it is very weak, and not reliably detectable even in a large study such as
UK Biobank. A previous study also showed little evidence of quadratic associations between genetic
liability for schizophrenia and number of children [8]. These sensitivity analyses further suggest that
the relationship between genetic liability for schizophrenia and number of sexual partners is linear in
this healthy population.
Cliff-edge fitness suggests that schizophrenia prevalence is sustained because the negative
reproductive effects in those with an underlying genetic liability and the disorder are offset by a
reproductive advantage to those who have an underlying genetic liability but do not develop the
disorder [8]. We therefore examined only part of the cliff-edge hypothesis by studying only those
without the disorder, testing whether there is a linear effect on reproductive success with increasing
genetic liability. Although it is hard to estimate the size of effect on fecundity necessary to sustain the
prevalence of schizophrenia (or indeed whether this effect size may fall within the confidence
intervals of our estimate), our results provide no support for a cliff-edge fitness effect maintaining
schizophrenia prevalence. However, in the modern environment (with available contraception), there
are limits to the conclusions we can make about historical evolutionary forces on schizophrenia-
associated alleles from these present-day fitness associations. We do find evidence of increased mating
success with increasing genetic liability which may proxy reproductive success in past environments
and partly explain how the disorder has been maintained in the population. We see stronger evidence
for a positive association between genetic liability for schizophrenia and number of sexual partners in
males than females, in line with sex differences in reproductive strategies [4]. As variance in
reproductive success is higher in males than in females, it has been argued that males obtain higher
reproductive benefits from additional matings than females [52]. It has been suggested that creative
displays are a form of sexual competition that reflect these evolutionary pressures [4,53]. It is possible
that the associations seen in females here are a by-product of male reproductive behaviour, although
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14there are, of course, also benefits to females of attracting additional mates, such as higher mate quality
[4]. We assume that, on average, increasing numbers of partners is a reasonable proxy for fitness;
however, number of sexual partners has probably also undergone changes since the introduction of
contraception, which has allowed for decoupling of sexual and reproductive partners. We therefore
cannot conclude that cliff-edge fitness has sustained the prevalence of schizophrenia within the
population and provide no evidence for a cliff-edge effect on current fitness.
This leaves us with two further theories for how schizophrenia prevalence is maintained. One is that
as schizophrenia is a highly heterogeneous disorder and exhibits a highly polygenic architecture, and
effects of genetic variants are individually too weak to be under negative selection [1,8,10]. Our
results are consistent with this possibility and suggest that identified schizophrenia risk variants are
not under strong selection in the general population. Another explanation is that mutation–selection
balance maintains the prevalence of schizophrenia; rare recurrent DNA copy number variants, which
are also risk factors for schizophrenia, are filtered out of the population by selection and replenished
by de novo mutations [9]. Rare copy number variants conferring risk to psychiatric illness are under
strong negative selection [8,9], with most persisting in the population for only two generations [9]. We
used results from GWAS, which mainly detect common alleles and therefore cannot determine
whether mutation–selection balance sustains the prevalence of schizophrenia through rare variants,
although rare variants have been shown to associate with the number of children [1,8]. Other
explanations could include an increased likelihood of symptom diagnosis, changes in the environment
[54,55] and/or selection bias. UK Biobank data are unrepresentative of the population, given a
response rate of approximately 5%, which may introduce selection bias [32,56]. This can generate
spurious results in genotypic associations when selection is based on phenotypes associated with the
genetic variants and could attenuate associations towards the null if schizophrenia-proneness and
increased number of children reduced participation [57–59]. Previous studies have found that higher
genetic liability for schizophrenia is associated with lower participation in cohort studies which could
bias estimates between genetic liability and traits that lead to non-participation in genetic associations
and MR [58,60].
A key strength of this study is the use of MR, which can provide stronger evidence of causality than
observational studies [18,61]. We showed agreement between various MR methods that rely on differing
assumptions and agreement between methods provides greater confidence in the robustness of the
results [62]. We further conducted a positive control analysis to confirm that our approach was valid.
Additionally, our MR offers large sample sizes which are necessary for investigating small effect sizes
common in such genetic analysis [43]. However, there are also some limitations that should be
considered with the current evidence. Firstly, MR relies on genetic variants naturally randomizing an
exposure, and therefore inferring causality from genetic liability for schizophrenia as the exposure
requires careful interpretation. Our outcome sample was not selected on schizophrenia status, so it
contained only few cases of diagnosed schizophrenia. Therefore, we assume that schizophrenia SNPs
are associated with subdiagnostic schizophrenia traits that could cause a reproductive advantage
within the wider population [4,13,15]. Although debated [63,64], schizophrenia symptoms have been
suggested to exist on a continuum, and this assumption could therefore be met [63,65–67]. Within
this, we assume that the instrumental variable assumptions are satisfied for this continuous liability to
provide a valid test of causality using the binary exposure [49]. Secondly, variants are non-specific,
and it is difficult to fully remove population structure, which can induce spurious associations
through confounding, even within a sample of European ancestry and adjusting for principal
components as we have done [30,68]. Thirdly, age at first birth was measured only in females in UK
Biobank, and therefore consists of a different population to the exposure data (which includes data
from both females and males). However, the correlation between male and female estimates for age at
first birth in a recent GWAS was high [28]. Similarly, the schizophrenia-associated genetic variants
used in our sex-stratified analyses were identified from a mixed sex population, although we used an
unweighted genetic score to minimize any bias. Lastly, the exposure and outcome samples were each
quality controlled for relatedness; however, it is not possible to determine whether participants had
relatives across the samples due to the use of summary-level GWAS data for our exposures.
The present study highlights the continued importance of investigating differential fertility and
contributes to understanding the maintenance of schizophrenia, and educational attainment, in the
population [3,20,69]. Educational attainment has previously been shown to predict human longevity
[70] and highlights how even traits with a positive effect on longevity can be maladaptive, although
other influences on educational attainment in the population are also identified [29]. This work
additionally demonstrates how epidemiological methods can be repurposed to study evolutionary
royalsocietypublishing.org/journal/rsos
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15theories. Future research should investigate causal methods for estimating nonlinear relationships as well
as other explanations for this evolutionary paradox, such as mutation–selection balance.
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